Literature DB >> 26850787

Treatment-resistant panic disorder: clinical significance, concept and management.

Mu-Hong Chen1, Shih-Jen Tsai2.   

Abstract

Panic disorder is commonly prevalent in the population, but the treatment response for panic disorder in clinical practice is much less effective than that in our imagination. Increasing evidence suggested existence of a chronic or remitting-relapsing clinical course in panic disorder. In this systematic review, we re-examine the definition of treatment-resistant panic disorder, and present the potential risk factors related to the treatment resistance, including the characteristics of panic disorder, other psychiatric and physical comorbidities, and psychosocial stresses. Furthermore, we summarize the potential pathophysiologies, such as genetic susceptibility, altered brain functioning, brain-derived neurotrophic factor, and long-term inflammation, to explain the treatment resistance. Finally, we conclude the current therapeutic strategies for treating treatment-resistant panic disorder from pharmacological and non-pharmacological views.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Definition; Panic disorder; Pathophysiology; Risk factors; Treatment-resistance

Mesh:

Year:  2016        PMID: 26850787     DOI: 10.1016/j.pnpbp.2016.02.001

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  8 in total

1.  Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review.

Authors:  Wicher A Bokma; Guido A A M Wetzer; Jurriaan B Gehrels; Brenda W J H Penninx; Neeltje M Batelaan; Anton L J M van Balkom
Journal:  Depress Anxiety       Date:  2019-06-23       Impact factor: 6.505

2.  Panic Attack Prediction Using Wearable Devices and Machine Learning: Development and Cohort Study.

Authors:  Chan-Hen Tsai; Pei-Chen Chen; Ding-Shan Liu; Ying-Ying Kuo; Tsung-Ting Hsieh; Dai-Lun Chiang; Feipei Lai; Chia-Tung Wu
Journal:  JMIR Med Inform       Date:  2022-02-15

3.  Effects of stressful life-events on DNA methylation in panic disorder and major depressive disorder.

Authors:  Darina Czamara; Alexa Neufang; Roman Dieterle; Stella Iurato; Janine Arloth; Jade Martins; Marcus Ising; Elisabeth E Binder; Angelika Erhardt
Journal:  Clin Epigenetics       Date:  2022-04-27       Impact factor: 7.259

Review 4.  Critical Issues in BDNF Val66Met Genetic Studies of Neuropsychiatric Disorders.

Authors:  Shih-Jen Tsai
Journal:  Front Mol Neurosci       Date:  2018-05-15       Impact factor: 5.639

5.  The course and clinical correlates of panic disorder during the postpartum period: a naturalistic observational study.

Authors:  Semra Aydogan; Faruk Uguz; Eda Yakut; Melike G Bayman; Kazim Gezginc
Journal:  Braz J Psychiatry       Date:  2020-10-23       Impact factor: 2.697

6.  Early and Objective Evaluation of the Therapeutic Effects of ADHD Medication through Movement Analysis Using Video Recording Pixel Subtraction.

Authors:  Ying-Han Lee; Chen-Sen Ouyang; Yi-Hung Chiu; Ching-Tai Chiang; Rong-Ching Wu; Rei-Cheng Yang; Lung-Chang Lin
Journal:  Int J Environ Res Public Health       Date:  2022-03-08       Impact factor: 3.390

7.  A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Authors:  Azmi Nasser; Tesfaye Liranso; Toyin Adewole; Nicholas Fry; Joseph T Hull; Gregory D Busse; Fatima Chowdhry; Andrew J Cutler; Nandita Joshi Jones; Robert L Findling; Stefan Schwabe
Journal:  J Clin Psychopharmacol       Date:  2021 Jul-Aug 01       Impact factor: 3.153

8.  Clinical implications of agoraphobia in patients with panic disorder.

Authors:  Jin Shin; Doo-Heum Park; Seung-Ho Ryu; Jee Hyun Ha; Seol Min Kim; Hong Jun Jeon
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.